GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 235 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $6,539,000 | +2312.9% | 96,027 | +1032.0% | 0.23% | +2775.0% |
Q2 2022 | $271,000 | 0.0% | 8,483 | -8.4% | 0.01% | -27.3% |
Q4 2021 | $271,000 | -92.7% | 9,263 | -89.9% | 0.01% | -90.5% |
Q1 2021 | $3,727,000 | +29.7% | 91,449 | +75.4% | 0.12% | -69.5% |
Q3 2020 | $2,874,000 | – | 52,126 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 460,000 | $14,872,000 | 13.19% |
VHCP Management II, LLC | 141,611 | $4,578,000 | 3.76% |
Perceptive Advisors | 1,186,630 | $38,363,000 | 2.84% |
RTW INVESTMENTS, LP | 175,156 | $5,663,000 | 1.87% |
Casdin Capital, LLC | 65,000 | $2,101,000 | 1.86% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,163,811 | $37,626,000 | 1.52% |
RA Capital Management | 457,142 | $14,779,000 | 1.46% |
VHCP Management, LLC | 60,691 | $1,962,000 | 1.19% |
Iguana Healthcare Management, LLC | 110,000 | $3,556,000 | 1.17% |
Partner Investment Management, L.P. | 15,634 | $505,000 | 0.83% |